Skip to main content
letter
. 2021 Apr 24;35(8):e483–e485. doi: 10.1111/jdv.17268

Table 1.

Demographics, history and clinical features in 11 patients with cutaneous manifestations after vaccine receipt

N Sex Age Vaccine dose Onset Clinical features Extracutaneous manifestations Allergy‐related history
1 F 67 1 day Itchy erythemato‐oedematous plaque at injection site N N
2 F 61 2 days Erythema & swelling of left foot dorsum N N
3 F 55 8 days Erythema and itch of face Y Y
4 F 59 3 days Diffuse erythematous rash Y Y
5 F 62 1 h Itchy erythemato‐oedematous plaque at injection site Y Y
6 F 38 1 h Erythema of both legs Y Y
7 M 56 1 h Urticaria at injection site N Y
8 F 56 5 h Diffuse erythematous rash of trunk N Y
9 M 29 7 days Erythema and swelling of left chest N Y
10 M 36 48 h Diffuse erythematous rash of trunk N N
11 M 32 2 days Urticarial rash, flare‐up of atopic dermatitis N Y

F, female; M, male; N, No; Y, yes.

Previous SARS‐CoV‐2 infection.